对比增强锥形束乳腺CT鉴别含DCIS成分乳腺病变
本研究回顾性纳入行术前CE-CBBCT的DCIS、DCISM和DCIS-IDC患者,训练队列164例,时间分离验证队列58例。分析临床病理与CE-CBBCT特征,建立logistic回归模型区分DCIS与浸润性病变以及DCISM与DCIS-IDC。CE-CBBCT特征随浸润状态而异,模型在验证队列AUC分别为0.785和0.817,但需前瞻性多中心外部验证。
要点
- DCIS与DCISM在垂直导管走行的最大范围及邻近血管征上有差异,提示这两项征象可能反映微浸润。
- DCISM与DCIS-IDC在病灶强化程度和病灶类型上有差异,阅片时需重点评估强化程度。
- 当前CE-CBBCT模型为探索性结果,尚未达到可直接用于术前决策的程度。
核心结论
- CE-CBBCT特征随浸润状态(DCIS、DCISM、DCIS-IDC)不同而呈现差异。
- 基于CE-CBBCT特征建立的探索性模型在时间分离验证队列中AUC分别为0.785和0.817,具有初步鉴别价值。
- 研究结论不支持当前直接临床实施,需前瞻性多中心外部验证。
研究设计与样本
- 回顾性研究,训练队列纳入2018年8月至2026年1月行术前CE-CBBCT的DCIS、DCISM或DCIS-IDC患者164例。
- 验证队列为同一机构2026年2月至2026年6月符合相同纳入标准的患者58例,构成时间分离验证。
- 参考标准为术后病理诊断,分组为DCIS、DCISM和DCIS-IDC三组。
关键影像表现/征象
- DCIS与DCISM在垂直导管走行的最大范围上存在差异(P=0.014)。
- DCIS与DCISM在邻近血管征上存在差异(P=0.005)。
- DCISM与DCIS-IDC在病灶强化程度上存在差异(P<0.001)。
- DCISM与DCIS-IDC在病灶类型上存在差异(P<0.001)。
诊断标准与关键数值
- 区分DCIS与浸润性病变的模型在训练队列AUC为0.815,在时间分离验证队列AUC为0.785。
- 区分DCISM与DCIS-IDC的模型在训练队列AUC为0.810,在时间分离验证队列AUC为0.817。
- 训练队列中前哨淋巴结转移、HER2状态、Ki-67表达和核分级在三组间差异均有统计学意义(均P<0.05)。
临床应用与阅片要点
- 阅片时对导管原位癌病例应关注垂直导管走行的最大范围及邻近血管征,以辅助判断是否存在微浸润。
- 对已提示微浸润的病灶,病灶强化程度和病灶类型可作为进一步区分DCISM与DCIS-IDC的影像参考。
- 当前CE-CBBCT征象不能单独用于术前分期决策,应结合临床病理信息综合判断。
局限性
- 本研究为单中心回顾性设计,验证队列与训练队列来自同一机构。
- 原文明确指出在临床实施前需要前瞻性多中心外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVE: Preoperative differentiation among ductal carcinoma in situ (DCIS), DCIS with microinvasion (DCISM), and DCIS with invasive ductal carcinoma (DCIS-IDC) remains challenging. We explored clinicopathological and contrast-enhanced cone-beam breast CT (CE-CBBCT) features associated with invasive status and developed exploratory stepwise models.
MATERIALS AND METHODS: Patients with DCIS, DCISM, or DCIS-IDC undergoing preoperative CE-CBBCT from August 2018 to January 2026 were retrospectively included in the training cohort, whereas patients meeting the same inclusion criteria at the same institution from February 2026 to June 2026 comprised a temporally separated validation cohort. Clinicopathological and CE-CBBCT features were compared among groups. Logistic regression models were developed to distinguish DCIS from invasive lesions and DCISM from DCIS-IDC using CE-CBBCT features.
RESULTS: 164 women were included in the training cohort and 58 in the validation cohort. In the training cohort, sentinel lymph node metastasis, human epidermal growth factor receptor 2 status, Ki-67 expression, and nuclear grade differed among groups (all P < 0.05). DCIS and DCISM differed in the maximum extent perpendicular to the ductal orientation (P = 0.014) and adjacent vessel sign (P = 0.005), whereas DCISM and DCIS-IDC differed in the degree of lesion enhancement and lesion type (both P < 0.001). The two models achieved areas under the receiver operating characteristic curves of 0.815 and 0.810 in the training cohort and 0.785 and 0.817, respectively, in the temporally separated validation cohort.
CONCLUSION: CE-CBBCT features varied with invasive status, and the exploratory models showed preliminary discriminatory value. However, prospective multicenter external validation is needed before clinical implementation.
引用
- Guo, Ma, Yin, et al. Contrast-Enhanced Cone-Beam Breast CT Features for Differentiation of Breast Lesions with a Ductal Carcinoma In Situ Component. Acad Radiol. 2026. PMID: 42711181. doi:10.1016/j.acra.2026.08.099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。